Literature DB >> 9156123

Haemopoietic growth factors.

N J Ketley1, A C Newland.   

Abstract

Haemopoietic growth factors are involved in the production of the various blood cells from progenitors in the bone marrow, making them useful in a range of clinical situations. The genes for several of them have been cloned and their production engineered by recombinant technology, making them widely available. Myeloid growth factors are used to support patients in the aftermath of chemotherapy and bone marrow transplantation and have potential application in the treatment of infectious diseases. Erythropoietin is widely used for patients with anaemia due to failure of marrow production, having established its effectiveness in chronic renal failure. Thrombopoietin has recently been described and may provide a means to alleviate thrombocytopenia. Current indications and areas of recent reappraisal are addressed in this review.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9156123      PMCID： PMC2431295          DOI： 10.1136/pgmj.73.858.215

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  40 in total

1.  Use of colony-stimulating factors in the treatment of acute myeloid leukemia.

Authors:  E H Estey
Journal:  Blood       Date:  1994-04-15       Impact factor: 22.113

2.  Blood. Thrombopoietin--at last.

Authors:  D Metcalf
Journal:  Nature       Date:  1994-06-16       Impact factor: 49.962

Review 3.  Routes to repopulation--a unification of the stochastic model and separation of stem-cell subpopulations.

Authors:  M Y Gordon; N M Blackett
Journal:  Leukemia       Date:  1994-06       Impact factor: 11.528

4.  Bone marrow transplants from peripheral blood.

Authors:  T L Holyoake; I M Franklin
Journal:  BMJ       Date:  1994-07-02

5.  Preliminary results of treatment with filgrastim for relapse of leukemia and myelodysplasia after allogeneic bone marrow transplantation.

Authors:  S Giralt; S Escudier; H Kantarjian; A Deisseroth; E J Freireich; B S Andersson; S O'Brien; M Andreeff; H Fisher; A Cork
Journal:  N Engl J Med       Date:  1993-09-09       Impact factor: 91.245

6.  Cells expressing human glucocerebrosidase from a retroviral vector repopulate macrophages and central nervous system microglia after murine bone marrow transplantation.

Authors:  W J Krall; P M Challita; L S Perlmutter; D C Skelton; D B Kohn
Journal:  Blood       Date:  1994-05-01       Impact factor: 22.113

7.  Randomized, double-blind, placebo-controlled, phase III study of recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to induction treatment of high-grade malignant non-Hodgkin's lymphomas.

Authors:  H H Gerhartz; M Engelhard; P Meusers; G Brittinger; W Wilmanns; G Schlimok; P Mueller; D Huhn; R Musch; W Siegert
Journal:  Blood       Date:  1993-10-15       Impact factor: 22.113

8.  Granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor: differential action on incisional wound healing.

Authors:  R W Jyung; L Wu; G F Pierce; T A Mustoe
Journal:  Surgery       Date:  1994-03       Impact factor: 3.982

9.  Haemopoietic growth factors in aplastic anaemia: a cautionary note. European Bone Marrow Transplant Working Party for Severe Aplastic Anaemia.

Authors:  J C Marsh; G Socie; H Schrezenmeier; A Tichelli; E Gluckman; P Ljungman; S R McCann; A Raghavachar; P Marin; J M Hows
Journal:  Lancet       Date:  1994-07-16       Impact factor: 79.321

10.  Placebo-controlled phase III trial of lenograstim in bone-marrow transplantation.

Authors:  C Gisselbrecht; H G Prentice; A Bacigalupo; P Biron; N Milpied; H Rubie; D Cunningham; M Legros; J L Pico; D C Linch
Journal:  Lancet       Date:  1994-03-19       Impact factor: 79.321
View more
  3 in total

1.  Hematopoietic effect of deer antler extract fermented by Bacillus subtilis on murine marrow cells.

Authors:  Yooheon Park; Hyeon-Son Choi; Hyun-Sun Lee; Hyung Joo Suh
Journal:  Nutr Res Pract       Date:  2015-09-10       Impact factor: 1.926

2.  Identification of predictive genetic signatures of Cytarabine responsiveness using a 3D acute myeloid leukaemia model.

Authors:  Haiyan Xu; Eric S Muise; Sarah Javaid; Lan Chen; Razvan Cristescu; My Sam Mansueto; Nicole Follmer; Jennifer Cho; Kimberley Kerr; Rachel Altura; Michelle Machacek; Benjamin Nicholson; George Addona; Ilona Kariv; Hongmin Chen
Journal:  J Cell Mol Med       Date:  2019-08-26       Impact factor: 5.310

3.  Low-intensity pulsed ultrasound alleviating myelosuppression of Sprague-Dawley rats after combined treating by paclitaxel and carboplatin.

Authors:  Dong Luo; Wenzhi Chen; Wei Wang; Junlin Chen; Haopeng Xu; Jinyun Chen; Yan Wang
Journal:  Transl Cancer Res       Date:  2021-03       Impact factor: 1.241
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.